David A Williams, MD

Trials

Studies that name David A Williams, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:15 UTC. Open this list on ClinicalTrials.gov

• N/A
  NCT02845596 · Unrelated Donor Transplant Versus Immune Therapy in Pediatric Severe Aplastic Anemia

  Michael Pulsipher · completed · Severe Aplastic Anemia · study chair
• Ph1
  NCT01260844 · Open Label, Single Dose, Non-randomized Study to Assess the Drug to Drug Interaction of Briakinumab on CYP Substrates.

  Abbott · withdrawn · Moderate to Severe Plaque Psoriasis · study director
• Ph3
  NCT01251614 · A Double Blind Study in Pediatric Subjects With Chronic Plaque Psoriasis, Studying Adalimumab vs. Methotrexate

  AbbVie (prior sponsor, Abbott) · completed · Plaque Psoriasis · study director

Grants

NIH projects from RePORTER, fetched 2026-11-12 08:15 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.